Technical analysis of Kiora Pharmaceuticals, Inc. (KPRX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across the United States. Its flagship therapeutic candidate, KIO-301, is a groundbreaking small molecule undergoing Phase 1 clinical trials.
Price Performance
| 1 month | +0.39% |
| 3 months | +2.77% |
| Year-to-date | +31.98% |
| 1 year | -1.89% |
| 3 years | -45.83% |
| 5 years | -99.64% |
52-Week Range
| 52-week High | $2.95 |
| 52-week Low | $1.76 |
| Avg Volume (90d) | 26K |
Technical Indicators
| SMA 50 | $2.57 |
| SMA 200 | $2.35 |
| Beta | -0.77 |
| 30-day Volatility (annualised) | 35.5% |
| Price vs SMA 50 | +1.1% |
| Price vs SMA 200 | +10.5% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.31 | |
| 2025-11 | $1.98 | -14.3% |
| 2025-12 | $1.97 | -0.5% |
| 2026-01 | $2.40 | +21.8% |
| 2026-02 | $2.09 | -12.9% |
| 2026-03 | $1.93 | -7.7% |
| 2026-04 | $2.35 | +21.8% |
| 2026-05 | $2.68 | +14.0% |
| 2026-06 | $2.63 | -1.9% |
| 2026-07 | $2.56 | -2.7% |
| 2026-08 | $2.51 | -2.0% |
| 2026-09 | $2.60 | +3.6% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $2.60 |
| Market Cap | $12M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.99 |
| EV / EBITDA | -0.38 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 8.97 |